Disclosure 0001437749-26-028846-2

SEC FORM 4

$1,626,750.00

Eton Pharmaceuticals, Inc. (ETON)

Sale of 25,000 shares at $65.07 per share.

Reporting Person Krempa David · Officer Title Chief Business Officer · Transaction Code S

Traded Aug 24, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001437749-26-028846 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Eton Pharmaceuticals, Inc. (ETON)." Disclosed 2026-08-24. https://desqlong.com/cards/0001437749-26-028846-2 (retrieved 2026-09-26).